Conference Program Home
  My Program

All Times EDT

CC = Walter E. Washington Convention Center   M = Marriott Marquis Washington, DC
* = applied session       ! = JSM meeting theme

Activity Details

443 Wed, 8/10/2022, 10:30 AM - 11:15 AM CC-Hall D
SPEED: Statistical Methods and Applications in Medical Research, Risk Analysis, and Marketing Part 2 — Contributed Poster Presentations
Biopharmaceutical Section, Section on Medical Devices and Diagnostics, Section on Statistics in Imaging, IMS, International Chinese Statistical Association, Section on Risk Analysis, Section on Statistics in Marketing
Chair(s): Michael Higgins, Kansas State University
01: Near Real-Time Surveillance of COVID-19 Vaccine Safety in the U.S. Food and Drug Administration Biologics Effectiveness and Safety (BEST) Initiative Data Network
Mao Hu, Acumen LLC; Patricia Lloyd, US Food and Drug Administration; Cindy Ke Zhou, US Food and Drug Administration; An-Chi Lo, Acumen LLC; Yoganand Chillarige, Acumen LLC; John Hornberger, Acumen LLC; Jeffrey Kelman, Centers for Medicare & Medicaid Services; Anne Marie Kline, Aetna; Cheryl N McMahill-Walraven, Aetna; Kandace L. Amend, Optum Epidemiology; John D Seeger, Optum Epidemiology; Daniel Beachler, HealthCore, Inc.; Alex Secora, IQVIA; Christian Reich, IQVIA; Azadeh Shoaibi, US Food and Drug Administration; Hui Lee Wong, US Food and Drug Administration; Steven Anderson, US Food and Drug Administration
02: Dose Finding via Efficacy Biomarkers and Toxicity Endpoints in Immuno-Oncology Clinical Trials
Yiding Zhang, Sanofi; Zhixing Xu, Sanofi; Ji Lin, Sanofi; Hui Quan, Sanofi
03: Practical Implementation of Randomization in a Complex Site-Level Stepped-Wedge Cluster Pragmatic Randomized Trial
Wen Wan, Section of General Internal Medicine, University of Chicago; Linda Rosul, Access community health network; Theodore Karrison, University of Chicago; Neda Laiteerapong, Section of General Internal Medicine, University of Chicago
04: A Two-Stage Method to Minimize the Expected Sample Size of a Single-Arm Study Under the Alternative Hypothesis
Xiaobo Zhong, Bristol Myers Squibb; Qian Li, Biostatistics and Strategic Consulting
05: Improving Dose-Escalation Design with Historical and Concurrent Trial Data
Abhishek Kumar Dubey, Bristol Myer Squibb; Arun Kumar Kumar, Bristol Myer Squibb; Kaushal Kumar Mishra, Bristol Myer Squibb
06: BGLAM: A Bayesian General Logistic Autoregressive Model for Correlated Binary Outcomes
Ahmad Hakeem Abdul Wahab, Janssen Pharmaceuticals; Arman Sabbaghi, Purdue University; Maggie O'Haire, Purdue University
07: Practical Guidance on Mixture Priors Specification in Oncology Dose Escalation Models
Frank Shen, Bristol Myers Squibb; Yanping Chen, Bristol Myers Squibb; Rong Liu, BMS
08: Overlap Weight-Based Adaptive Bayesian Commensurate Prior for Augmenting the Control Arm of a Randomized Controlled Trial
Yeonil Kim, Merck & Co., Inc. ; Erina Paul, Merck & Co., Inc.
09: Power Analysis for Longitudinal Cluster Randomized Trials with Binary Outcomes
Jijia Wang, UT Southwestern Medical Center
10: Association of COVID Vaccine Hesitancy and Vaccine Misinformation Using Google Trends Analytics Vaccine Hesitancy
Lan Gao, The University of Tennessee at Chattanooga
11: Extending the Weighted Generalized Score Statistic for Comparison of Correlated Means
Aaron D. Jones, Duke University; Andrzej S. Kosinski, Duke University
12: Can Cutaneous Squamous Cell Carcinoma Be Properly Graded? Investigation of the Differentiation Grading Among Dermatopathologists
Yevgeniya Gokun, The Ohio State University; Xueliang Pan, The Ohio State University; David Carr, The Ohio State University; Katie Shahwan, The Ohio State University; Jessica Nash, The Ohio State University
13: Evaluation of Patient-Reported Outcomes Using Kappa Statistics
Saryet Kucukemiroglu, Food and Drug Administration; Manasi Sheth, Food and Drug Administration
14: Statistical Considerations When Evaluating Diagnostic Devices with Categorical Output
Manasi Sheth, Food and Drug Administration
15: Homogeneity Test for Ordinal ROC Regression and Application to Facial Recognition
Ty Nguyen, University of Central Florida; Larry Tang, University of Central Florida
16: Club Exco: Clustering Brain Extreme Communities from Multi-Channel EEG Data
Matheus Bartolo Guerrero, King Abdullah University of Science and Technology; Raphael Huser, King Abdullah University of Science and Technology (KAUST); Hernando Ombao, King Abdullah University of Science and Technology
17: Large-Scale Correlation Screening Under Dependence for Brain Functional Connectivity Inference
HanĂ¢ LBATH, Univ. Grenoble Alpes, CNRS, Inria, Grenoble INP, LJK; Alexander Petersen, Brigham Young University; Sophie ACHARD, Univ. Grenoble Alpes, CNRS, Inria, Grenoble INP, LJK
18: Correcting Under-Reporting in Cyber Incidents
Seema Sangari, Kennesaw State University; Eric Dallal, Verisk
19: Outcome-Dependent Sampling on Posterior Estimates of Salesperson Rankings
Neil Mercer, Google LLC; Frank Yoon, Google LLC; Ignacio Martinez, Google LLC
20: A Framework for Measuring Influencer Marketing
Gary Cohen,; Vanja Dukic,